MARF Continues to Push Research on the Molecular Biology of Mesothelioma

Funded mainly by asbestos victims and asbestos plaintiff’s lawyers, The Mesothelioma Applied Research Foundation continues to fund molecular research mesothelioma, and holds increasingly frequent meetings that include research presentations. The most recent meeting was in March 2013 and included multiple sessions on the genetics and molecular biology of mesothelioma. The full agenda is online here. Set out below are the main sessions on science – note especially the final "closed" session on science.

The speakers included some significant physicians at significant cancer centers. One is Dr. Joseph Testa, a mesothelioma genetic mutation researcher at the Fox Chase Cancer Center. Another is Dr. Lee Krug of Memorial Sloan Kettering – he chairs its mesothelioma program.

10:00 AM 12:00 PM moderated by

Joseph R. Testa, PhD, FACMG News from the genetics front

2:00 PM 3:45 PM moderated by

Mary Hesdorffer, NP Novel research findings overview

4:00 PM 5:00 PM moderated by

Lee Krug, MD Pharma Speaks Up

9:15 AM 12:00 PM moderated by

Mary Hesdorffer, NP multidisciplinary panel to promote interaction between clinicians and researchers to achieve the best possible outcome for mesothelioma patients

2:00 PM 5:00 PM moderated by

Lee Krug, MD Closed Science Session

#Asbestos